Protocol summary

Study aim
Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with ADHD
Design
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 30 patients. Allocation Concealment method
Settings and conduct
The subjects of the research will be selected from ADHD sufferers, who referred to the pediatric psychiatric clinic in Ibn Sina Hospital in the second half of 1401. the intervention group will receive the syrup. The amount and safety of the above dose have been shown in previous studies and in the control group, in addition to the standard treatment, placebo syrup with a dose of 10 cc per day in two divided doses will be added to the standard medicine. The same color as herbal syrup is prepared in the same jars. At the beginning of the study and at 3 and 6 weeks, the patients were evaluated with the Attention Deficit Hyperactivity Disorder (ADHD-RS) and Revised Children's Manifest Anxiety Scale (RCMAS). The duration of the intervention in both groups is 6 weeks.
Participants/Inclusion and exclusion criteria
Patients suffering from ADHD disorder according to DSM V criteria, absence of other systemic and psychiatric disorders, IQ is within the normal range, their age is 7-12 years, and at least three months have passed since their standard drug treatment, and the informed consent form is completed Exclusion criteria: Patient refusal to continue treatment, occurrence of a systemic disease, initiation of new psychiatric treatment or new onset psychiatric disorder, drug side effects
Intervention groups
In addition to the standard treatment, the intervention group will be received dose of 0.2 cc per kilogram of weight The control group will be received a placebo syrup similar to herbal medicine
Main outcome variables
ADHD-RS scoring questionnaire The Revised Children's Manifest Anxiety Scale (RCMAS)

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20221001056065N1
Registration date: 2022-11-07, 1401/08/16
Registration timing: registered_while_recruiting

Last update: 2022-11-07, 1401/08/16
Update count: 0
Registration date
2022-11-07, 1401/08/16
Registrant information
Name
Maedeh Kamrani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3700 2202
Email address
kamranim@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-11-01, 1401/08/10
Expected recruitment end date
2023-04-30, 1402/02/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with Attention Deficit Hyperactivity Disorder
Public title
Efficacy evaluation of the Melissa officinalis syrup in treatment of children's anxiety symptoms with Attention Deficit Hyperactivity Disorder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
The patient with DSM V ADHD criteria, Absence of other systemic or psychiatric disorders, IQ in the normal range at least three months have passed since their standard drug treatment, Completion of the informed consent form by the parent
Exclusion criteria:
Age
From 7 years old to 12 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
Sample size
Target sample size: 30
Randomization (investigator's opinion)
Randomized
Randomization description
Block randomization using https://www.sealedenvelope.com Allocation Concealment method: To ensure equal number of study subjects in two groups, permutation block method was used. For this purpose, we will use the website www.sealedenvelope.com in such a way that the number of 8 blocks of 4 members will be randomly created through the above site.
Blinding (investigator's opinion)
Double blinded
Blinding description
Sealed envelopes
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
School of Medicine, Mashhad University of Medical Sciences
Street address
Horameli St., Ibn Sina Hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
919583134
Approval date
2022-07-26, 1401/05/04
Ethics committee reference number
IR.MUMS.MEDICAL.REC.1401.285

Health conditions studied

1

Description of health condition studied
Attention Deficit Hyperactivity Disorder
ICD-10 code
F90.0
ICD-10 code description
Attention-deficit hyperactivity disorder, predominantly inattentive type

Primary outcomes

1

Description
Revised Children's Anxiety Scale
Timepoint
in 3 and 6 weeks
Method of measurement
The amount of change in the revised children's anxiety scale questionnaire

2

Description
Attention deficit hyperactivity disorder scoring scale questionnaires
Timepoint
in 3 and 6 weeks
Method of measurement
The amount of change in attention deficit hyperactivity disorder scoring scale

Secondary outcomes

1

Description
Revised Children's Manifest Anxiety Scale score
Timepoint
week 3 and 6
Method of measurement
The amount of change in the anxiety score

Intervention groups

1

Description
Intervention group: Melissa officinalis syrup of Ehyateb Daru Tabiat company with a dose of 0.2 cc per kilogram of weight in two divided doses recipients
Category
Treatment - Drugs

2

Description
Control group: Placebo syrup with a dose of 10 cc per day in two doses recipients
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Ibn Sina Hospital
Full name of responsible person
Mojtaba Rezaee
Street address
Hor Ameli Street, Ibn Sina Hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
919583134
Phone
+98 51 3700 2202
Email
Maedeh.kamrani@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Majid Ghayour Mobarhan
Street address
Mashhad, University Street, Beside Hoveyzeh Cinema, Qurashi Building, Research and Technology Vice, Chancellor
City
Mashhad
Province
Razavi Khorasan
Postal code
9138813944
Phone
+98 51 3843 0249
Email
vcresraech@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Fatemeh Moharari
Position
Professor
Latest degree
Subspecialist
Other areas of specialty/work
Psychiatrics
Street address
Horameli St
City
Mashhad
Province
Razavi Khorasan
Postal code
919583134
Phone
+98 51 3700 2202
Email
MoharariF1@mums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Fatemeh Moharari
Position
Professor
Latest degree
Subspecialist
Other areas of specialty/work
Psychiatrics
Street address
Horameli St
City
Mashhad
Province
Razavi Khorasan
Postal code
919583134
Phone
+98 51 3700 2202
Email
MoharariF1@mums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mojtaba Rezaee
Position
Psychiatry resident
Latest degree
Medical doctor
Other areas of specialty/work
Psychiatrics
Street address
Hor Ameli Street, Ibn Sina Hospital
City
Mashhad
Province
Razavi Khorasan
Postal code
919583134
Phone
0517002202
Email
dr.rezaee20@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
After completing the study and obtaining permission from the Research Vice-Chancellor of Mashhad University of Medical Sciences, the researchers are ready to publish the results of the study in the form of an article.
When the data will become available and for how long
After the completion of the project (about one year after starting the work) and the resident's defense of his/her thesis, the researchers are ready to publish the results.
To whom data/document is available
Officials of Mashhad University of Medical Sciences and, therapists working in the field of mental health
Under which criteria data/document could be used
For the purpose of clinical use of the obtained results in the treatment of patients and in the event of the absence of clinical complications during the research
From where data/document is obtainable
Mashhad University of Medical Sciences, Research department
What processes are involved for a request to access data/document
Refer to research unit of Mashhad Medical Sciences Faculty, Dissertations Unit and obtain access permission
Comments
Loading...